HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Differentiation of opiate receptors in the brain by the selective development of tolerance.

Abstract
The selective development to either the delta-opiate receptor agonist D-Ala2,D-Leu5-enkephalin (DADL) or the mu-agonist sufentanyl (SUF) has been studied in the central nervous system of rats by use of osmotic minipumps for chronic administration of the drugs. The opiate-sensitive parameters analgesia and catatonia were investigated. Chronic intracerebroventricular infusion of DADL for 7 days produced a 15-fold shift in that for catatonia. In these rats, the potency of SUF in inducing analgesia and catatonia did not differ between DADL-treated animals and saline-infused controls. Similarly, chronic infusion of SUF resulted in tolerance towards SUF for both analgesia and catatonia. In these animals, DADL displayed a similar degree of tolerance w.r.t. its ability to evoke analgesia, whilst no tolerance could be detected for DADL-induced catatonia. The data indicate that prolonged stimulation of specific opiate receptors in the brain by selective agonists may bring about the selective development of tolerance for particular receptors. The data conflict with the notion that mu-receptors specifically mediate analgesia and delta-receptors catatonia.
AuthorsR Schulz, M Wüster, A Herz
JournalPharmacology, biochemistry, and behavior (Pharmacol Biochem Behav) Vol. 14 Issue 1 Pg. 75-9 (Jan 1981) ISSN: 0091-3057 [Print] United States
PMID6258177 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Enkephalins
  • Receptors, Opioid
Topics
  • Animals
  • Brain (metabolism)
  • Catalepsy (chemically induced)
  • Dose-Response Relationship, Drug
  • Drug Tolerance
  • Enkephalins (pharmacology)
  • Humans
  • Male
  • Rats
  • Receptors, Opioid (classification)
  • Vocalization, Animal (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: